Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer
Hong, J.; Kohutek, Z.; Zhang, H.; Karnoub, E.-R.; Kappagantula, R.; Wood, L. D.; Iacobuzio-Donahue, C.
Show abstract
We performed WES of 250 unique tumor tissues from 30 multiregion sampled pancreatic cancer research autopsies from patients diagnosed with advanced stage disease. We find that most genetic alterations in PDAC occur in a subclonal manner, and some genes occurred in a subclonal manner exclusively. Convergent evolution within the TGF{beta} pathway was also identified as a common feature of advanced stage disease, with SMAD4 inactivation more common among metastatic PDACs compared to inactivation of TGF{beta} surface receptors that was more common in locally advanced tumors. The mode of clinical management (radiation versus chemotherapy) contributed distinct mutational signatures yet these mutations are not predicted to have functional relevance to tumor progression. Overall, these findings provide a first definition of the genetic features that distinguish among patients with locally advanced versus metastatic PDAC. These findings may have clinical relevance in upfront clinical decision making for the optimal candidates for neoadjuvant therapy.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Oncogenic RAS activity predicts response to chemotherapy and outcome in lung adenocarcinoma 97%
- Single-Cell RNA Sequencing Reveals the Effects of Chemotherapy on Human Pancreatic Adenocarcinoma and its Tumor Microenvironment 97%
- The genomic and epigenomic evolutionary history of papillary renal cell carcinomas 97%
Similar papers in this journal
- Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high grade serous ovarian carcinoma 97%
- Cancer mutational processes vary in their association with replication timing and chromatin accessibility 96%
- Pharmacologically targeting KRASG12D in PDAC models:tumor cell intrinsic and extrinsic impact 95%
Similar papers in this journal
Similar papers in this journal
- Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer 96%
- Recurrent disruption of tumour suppressor genes in cancer by somatic mutations in cleavage and polyadenylation signals 95%
- Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. 94%
Similar papers in this journal
- Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics 96%
- Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers 96%
- Single-Cell Spatial Proteomics Analyses of Head and Neck Squamous Cell Carcinoma Reveal Tumor Heterogeneity and Immune Architectures Associated with Clinical Outcome 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.